Atropos Group

Website

Atropos Group Inc.

3 Investors
HealthTech, Real-World Evidence, AI
ARLINGTON, VA

Atropos Health is a healthcare technology company, spun out of Stanford University, that provides a platform to bridge the evidence gap in clinical decision-making. It utilizes real-world data and artificial intelligence to generate personalized evidence, helping clinicians and researchers make informed decisions for patient care and accelerate medical studies.

Products & Team

GENEVA OS™ (Generative Evidence Acceleration Operating System)

Clinical Intelligence PlatformSeed

GENEVA OS™ is the core operating system that serves as the foundation for Atropos Health's offerings. It is installed on an organization's cloud environment, enabling them to leverage their own data to rapidly generate transparent, publication-grade real-world evidence.

Value Proposition

The system addresses the critical 'evidence gap' in healthcare by providing rapid, data-driven insights for clinical questions that are not adequately answered by existing medical literature, thereby helping to personalize treatment decisions.

Pain Points

Customers face the challenge of making informed decisions for individual patients, especially in complex cases where clinical trial data is lacking or inapplicable. They also need to accelerate research and development timelines and demonstrate value in a value-based care environment, all of which are hindered by the slow, manual process of traditional evidence generation.

Generates evidence in minutes, a significant reduction from the months traditional methods require.Built to produce transparent and accurate results while eliminating the risk of AI 'hallucinations'.Operates on a federated model, analyzing data within an institution's firewall to maximize security and privacy.Enables evidence generation across a wide network of de-identified patient records.
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
ARLINGTON, VA
Primary headquarters

Funding History

Total Raised:
$6.0M
E

Option to Acquire Offering

Closed
July 2025
$6.0M
Raised
Progress
100%
Raised
$6.0M
Target
$6.0M
#000208378125000001